PLURI INC (PLUR:NASDAQ)
$1.63 -0.085 (-4.9563%)
Analysed PLURI INC (PLUR:NASDAQ) News Sources
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved
22-12-2025
yahoo.com
Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials
22-01-2026
yahoo.com
Pluri showcases cell expansion platform as Resbiomed program advances
09-02-2026
yahoo.com
Pluri: Fiscal Q2 Earnings Snapshot
12-02-2026
yahoo.com
Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent
18-02-2026
yahoo.com
Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement
26-03-2026
yahoo.com
EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug
01-05-2026
benzinga.com
Pluri Insider Ups Holding During Year
28-05-2026
yahoo.com
Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In
30-05-2026
yahoo.com
Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing
02-06-2026
yahoo.com
What is the current price of PLURI INC (PLUR:NASDAQ)?
The current price of PLURI INC (PLUR:NASDAQ) is $1.63.
PLURI INC (PLUR:NASDAQ) absolute price change since previous trading day?
The absolute price change of PLURI INC (PLUR:NASDAQ) since the previous trading day is $-0.085.
PLURI INC (PLUR:NASDAQ) percentage price change since previous trading day?
The percentage price change of PLURI INC (PLUR:NASDAQ) since the previous trading day is -4.9563%.
What is the most recent average sentiment score for PLURI INC (PLUR:NASDAQ)?
The most recent average sentiment score for PLURI INC (PLUR:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for PLURI INC (PLUR:NASDAQ)?
The most recent sentiment for PLURI INC (PLUR:NASDAQ) is .
SEC-8K** Filing Available For PLURI INC (PLUR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.